Lucid Tala vs Resound Vivia 9 60S microRIE

The Lucid Tala is a premium-priced OTC hearing aid at $1,300, earning an A grade with a SoundScore of 4.6/5 in our lab testing. Ranking #4 among 65 OTC hearing aids tested, it places in the top 5% of its category and has received HearAdvisor's Expert's Choice Award in both 2023 and 2024. Speech performance is a clear strength. Speech in Quiet scores an excellent 4.6/5, measuring 1.85 points above the category average. Speech in Noise reaches a solid 3.0/5, which is 1.56 points above the OTC average of 1.48—a meaningful advantage for conversations in challenging environments. Music streaming also performs well at 3.0/5, exceeding the category average by 1.08 points. The primary weakness is feedback handling, which scores a low 1.7/5 in our tuned testing—2.84 points below the category average of 4.54. This suggests users may experience more whistling or feedback artifacts than typical OTC devices. Own-voice comfort is mixed at 2.6/5, sitting just above the category average but not standing out in absolute terms. The Lucid Tala is best suited for users who prioritize speech clarity and are willing to pay premium OTC pricing for strong intelligibility performance. Those highly sensitive to feedback may want to consider alternatives. At this price point, comparable options include the Audicus Omni 2, though budget-conscious shoppers might explore lower-priced devices like the Elehear Beyond or Yeasound RIC700, which also deliver strong sound performance in our testing.

The Resound Vivia 9 60S microRIE is a premium prescription behind-the-ear hearing aid released in 2025, currently available at $3,798. In HearAdvisor's lab testing, it earned a B grade with a SoundScore of 3.9/5, ranking #27 of 36 prescription hearing aids tested. This device demonstrates a mixed performance profile in our testing. Own-voice comfort is a notable strength, scoring 3.4/5—a solid result that sits 0.65 points above the category average, which may appeal to users sensitive to the hollow or boomy sound of their own speech. Speech clarity in quiet environments also performs well at 3.4/5, slightly above the category average. However, the Vivia 9 shows significant limitations in challenging listening situations. Speech in noise scored just 1.1/5, falling 0.81 points below the prescription hearing aid average—a substantial gap that suggests difficulty in restaurants, group conversations, or other noisy environments. Feedback handling, while strong in absolute terms at 4.2/5, still lands 0.51 points below what we typically see from prescription devices. Music streaming quality is mixed at 2.6/5, essentially matching the category average. At this premium price point, the Vivia 9 faces stiff competition. Several same-priced alternatives, including the Phonak Sphere Infinio and Oticon Intent, achieved notably higher overall scores in our testing. Consumers prioritizing noise performance may want to explore these options or consider lower-priced alternatives like the Sennheiser All Day Clear that delivered stronger overall results in our lab.